Key facts
- ZuriMED Technologies’s last known valuation is $37.3M.
- It has raised $20.8M; the latest was Later Stage VC ($2.6M) in Nov 2024.
- Notable investors include Venture Kick, Innosuisse, Venture (Switzerland), ETH Zürich Foundation, Balgrist Beteiligungs — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for ZuriMED Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for ZuriMED Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZuriMED Technologies
Developer of a surgical fixation technology designed for anterior cruciate ligament reconstruction. The company utilizes a mechanical interlocking method that secures medical patch fibers directly into soft tissue without the use of interference screws, reducing surgical steps and simplifying attachment procedures, operating similarly to a surgical sewing mechanism, offering reliably strong fixations that help surgeons perform procedures efficiently and enabling patients to experience faster recovery with reduced pain and tissue trauma.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2015
- Employees
- 34
- Website
- zurimed.com/
- Ownership
- Privately Held (backing)
ZuriMED Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZuriMED Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZuriMED Technologies in its N-PORT filings yet. We sweep new filings monthly.